KD
Therapeutic Areas
Celon Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Innovative Oncology Program(s) | Cancers | Not Disclosed |
| Innovative Neurology Program(s) | Neurological Diseases | Not Disclosed |
| Innovative Metabolic Program(s) | Diabetes & Metabolic Disorders | Not Disclosed |
| Generic Products Portfolio | Various | Approved/Commercial |
Leadership Team at Celon Pharma
MW
Maciej Wieczorek, PhD
CEO, President of the Management Board
BS
Bartosz Szałek
CFO, Member of the Management Board
MS
Małgorzata Stokrocka
CDOO, Member of the Management Board
RR
Robert Rzemiński
Chairman of the Supervisory Board
BG
Bogusław Galewski
Member of the Supervisory Board
UW
Urszula Wieczorek
Member of the Supervisory Board
AW
Artur Wieczorek
Member of the Supervisory Board
KK
Krzysztof Kaczmarczyk
Member of the Supervisory Board